Zobrazeno 1 - 10
of 21
pro vyhledávání: '"David Scheie"'
Autor:
Otto M. Henriksen, Adam E. Hansen, Aida Muhic, Lisbeth Marner, Karine Madsen, Søren Møller, Benedikte Hasselbalch, Michael J. Lundemann, David Scheie, Jane Skjøth-Rasmussen, Hans S. Poulsen, Vibeke A. Larsen, Henrik B. W. Larsson, Ian Law
Publikováno v:
Henriksen, O M, Hansen, A E, Muhic, A, Marner, L, Madsen, K, Møller, S, Hasselbalch, B, Lundemann, M J, Scheie, D, Skjøth-Rasmussen, J, Poulsen, H S, Larsen, V A, Larsson, H B W & Law, I 2022, ' Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [ 18 F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 13, pp. 4677-4691 . https://doi.org/10.1007/s00259-022-05917-3
Purpose Both amino acid positron emission tomography (PET) and magnetic resonance imaging (MRI) blood volume (BV) measurements are used in suspected recurrent high-grade gliomas. We compared the separate and combined diagnostic yield of simultaneousl
Autor:
Sverre Heim, Torstein R. Meling, Anita Sveen, Lina Cekaite, Petter Brandal, Marine Jeanmougin, Ragnhild A. Lothe, David Scheie, Annette Bentsen Håvik, Guro Elisabeth Lind, Trude H. Ågesen
Publikováno v:
Molecular Oncology
Jeanmougin, M, Håvik, A B, Cekaite, L, Brandal, P, Sveen, A, Meling, T R, Ågesen, T H, Scheie, D, Heim, S, Lothe, R A & Lind, G E 2020, ' Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment ', Molecular Oncology, vol. 14, no. 5, pp. 1016-1027 . https://doi.org/10.1002/1878-0261.12668
Molecular Oncology, Vol 14, Iss 5, Pp 1016-1027 (2020)
Molecular Oncology, Vol. 14, No 5 (2020) pp. 1016-1027
Jeanmougin, M, Håvik, A B, Cekaite, L, Brandal, P, Sveen, A, Meling, T R, Ågesen, T H, Scheie, D, Heim, S, Lothe, R A & Lind, G E 2020, ' Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment ', Molecular Oncology, vol. 14, no. 5, pp. 1016-1027 . https://doi.org/10.1002/1878-0261.12668
Molecular Oncology, Vol 14, Iss 5, Pp 1016-1027 (2020)
Molecular Oncology, Vol. 14, No 5 (2020) pp. 1016-1027
Glioblastoma (GBM), the most aggressive form of brain cancer, is characterized by a high level of molecular heterogeneity, and infiltration by various immune and stromal cell populations. Important advances have been made in deciphering the microenvi
Autor:
Karina Juhl, Andreas Kjaer, Jane Skjøth-Rasmussen, Carl Christian Larsen, Aleena Azam, David Scheie
Publikováno v:
Acta neurochirurgica. 164(1)
Meningiomas are benign lesion although anot insignificant number experiences recurrences despite Simpson grade 1 removal. FG001 is a compound with a fluorophore (ICG) that binds to a urokinase-type plasminogen activator receptor (uPAR) and is current
Autor:
Christelle Dufour, Johannes Gojo, Sandra Jacobs, Barry Pizer, Dominik Sturm, Torsten Pietsch, Stefan Rutkowski, Christine Haberler, Nicolas U. Gerber, Teresa de Rojas, Peter Hauser, Ulrich Schüller, Peter C. Burger, Marta Perek-Polnik, Martin Mynarek, Jaeho Cho, Matija Snuderl, Bernward Zeller, Michal Zapotocky, Maura Massimino, Robert Kwiecien, Dominique Figarella-Branger, Andrey Golanov, Charles G. Eberhart, Stefan M. Pfister, Daniel Alderete, Thomas S. Jacques, Ella Kumirova, Konstantin Okonechnikov, Astrid Sehested, Ofelia Cruz, Andrey Korshunov, Björn Ole Juhnke, Niels Bovenschen, Jessica C Pickles, David Sumerauer, Cynthia Hawkins, David Scheie, Eugene Hwang, Pieter Wesseling, Barbara von Zezschwitz, Felice Giangaspero, Marcel Kool, Elizabeth Schepke, Andreas von Deimling, Marco Gessi, Dannis G. van Vuurden, Maximilian Wechsung, Miklós Garami, David Capper, Katja von Hoff, Maria Joao Gil-da-Costa, Maria Łastowska, Felix Schmitt-Hoffner, Olga Zheludkova, Lucas Moreno, Michael A. Grotzer, Frank Konietschke, Marina Ryzhova, Elisabeth J. Rushing, Irene Slavc
Publikováno v:
Neuro-Oncology 23(9), 1597-1611 (2021). doi:10.1093/neuonc/noab136
Neuro-Oncology
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Neuro-Oncology, Oxford University Press (OUP), 2021, ⟨10.1093/neuonc/noab136⟩
Neuro-Oncology, 23(9), 1597-1611. Oxford University Press
von Hoff, K, Haberler, C, Schmitt-Hoffner, F, Schepke, E, de Rojas, T, Jacobs, S, Zapotocky, M, Sumerauer, D, Perek-Polnik, M, Dufour, C, van Vuurden, D, Slavc, I, Gojo, J, Pickles, J C, Gerber, N U, Massimino, M, Gil-da-Costa, M J, Garami, M, Kumirova, E, Sehested, A, Scheie, D, Cruz, O, Moreno, L, Cho, J, Zeller, B, Bovenschen, N, Grotzer, M, Alderete, D, Snuderl, M, Zheludkova, O, Golanov, A, Okonechnikov, K, Mynarek, M, Juhnke, B O, Rutkowski, S, Schüller, U, Pizer, B, von Zezschwitz, B, Kwiecien, R, Wechsung, M, Konietschke, F, Hwang, E I, Sturm, D, Pfister, S M, von Deimling, A, Rushing, E J, Ryzhova, M, Hauser, P, Łastowska, M, Wesseling, P, Giangaspero, F, Hawkins, C, Figarella-Branger, D, Eberhart, C, Burger, P, Gessi, M, Korshunov, A, Jacques, T S, Capper, D, Pietsch, T & Kool, M 2021, ' Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities : Results of an international, retrospective study ', Neuro-Oncology, vol. 23, no. 9, pp. 1597-1611 . https://doi.org/10.1093/neuonc/noab136
Neuro Oncol
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Neuro-Oncology, 2021, ⟨10.1093/neuonc/noab136⟩
Neuro-Oncology
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Neuro-Oncology, Oxford University Press (OUP), 2021, ⟨10.1093/neuonc/noab136⟩
Neuro-Oncology, 23(9), 1597-1611. Oxford University Press
von Hoff, K, Haberler, C, Schmitt-Hoffner, F, Schepke, E, de Rojas, T, Jacobs, S, Zapotocky, M, Sumerauer, D, Perek-Polnik, M, Dufour, C, van Vuurden, D, Slavc, I, Gojo, J, Pickles, J C, Gerber, N U, Massimino, M, Gil-da-Costa, M J, Garami, M, Kumirova, E, Sehested, A, Scheie, D, Cruz, O, Moreno, L, Cho, J, Zeller, B, Bovenschen, N, Grotzer, M, Alderete, D, Snuderl, M, Zheludkova, O, Golanov, A, Okonechnikov, K, Mynarek, M, Juhnke, B O, Rutkowski, S, Schüller, U, Pizer, B, von Zezschwitz, B, Kwiecien, R, Wechsung, M, Konietschke, F, Hwang, E I, Sturm, D, Pfister, S M, von Deimling, A, Rushing, E J, Ryzhova, M, Hauser, P, Łastowska, M, Wesseling, P, Giangaspero, F, Hawkins, C, Figarella-Branger, D, Eberhart, C, Burger, P, Gessi, M, Korshunov, A, Jacques, T S, Capper, D, Pietsch, T & Kool, M 2021, ' Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities : Results of an international, retrospective study ', Neuro-Oncology, vol. 23, no. 9, pp. 1597-1611 . https://doi.org/10.1093/neuonc/noab136
Neuro Oncol
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Neuro-Oncology, 2021, ⟨10.1093/neuonc/noab136⟩
Background Only few data are available on treatment-associated behavior of distinct rare CNS embryonal tumor entities previously treated as “CNS-primitive neuroectodermal tumors” (CNS-PNET). Respective data on specific entities, including CNS neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfda65d63cf766e727aec652e64d395
Autor:
Jeanette K, Petersen, David, Scheie, Henning B, Boldt, Benedicte P, Ulhøi, Marianne S, Ettrup, Bjarne W, Kristensen
Publikováno v:
Ugeskrift for laeger. 181(6)
Diagnostics of tumours of the central nervous system has for decades been based entirely on microscopy. A con-siderable degree of diagnostic interobserver variability has been observed due to imprecise histological criteria. In the revised WHO classi
Autor:
Helle Broholm, Karin de Stricker, Morten Grauslund, Huda Haidar Abdallah Kufaishi, Eva Løbner Lund, Linea Cecilie Melchior, David Scheie
Publikováno v:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 127(5)
Until recently, diagnostics of brain tumors were almost solely based on morphology and immunohistochemical stainings for relatively unspecific lineage markers. Although certain molecular markers have been known for longer than a decade (combined loss
Autor:
Lisbeth, Marner, Karsten, Nysom, Astrid, Sehested, Lise, Borgwardt, René, Mathiasen, Otto Mølby, Henriksen, Michael, Lundemann, Per, Munck Af Rosenschöld, Carsten, Thomsen, Lars, Bøgeskov, Jane, Skjøth-Rasmussen, Marianne, Juhler, Anders, Kruse, Helle, Broholm, David, Scheie, Torsten, Lauritsen, Julie Lyng, Forman, Peder Skov, Wehner, Liselotte, Højgaard, Ian, Law
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 60(8)
Complete resection is the treatment of choice for most pediatric brain tumors, but early postoperative MRI for detection of residual tumor may be misleading because of MRI signal changes caused by the operation. PET imaging with amino acid tracers in
Autor:
Astrid K. Gnekow, David A. Walker, Daniela Kandels, Susan Picton, null Giorgio Perilongo, Jacques Grill, Tore Stokland, Per Eric Sandstrom, Monika Warmuth-Metz, Torsten Pietsch, Felice Giangaspero, René Schmidt, Andreas Faldum, Denise Kilmartin, Angela De Paoli, Gian Luca De Salvo, Irene Slavc, Giorgio Perilongo, Sue Picton, David Walker, Per Erik Sandstrom, Niels Clausen, Mikko Arola, Olafur Gisli Jonsson, Ofelia Cruz, Aurora Navajas, Anna Teijeiro, Chantal Kalifa, Marie-Anne Raquin, Joris Verlooy, Volkmar Hans, Wolfram Scheurlen, Johannes Hainfellner, James Ironside, Keith Robson, Kari Skullerud, David Scheie, null NN, Marie-Madeleine Ruchoux, Anne Jouvet, Dominique Figarella-Branger, Arielle Lellouch-Toubiana, Daniela Prayer, Milena Calderone, Tim Jaspan, Soren Jacob Bakke, Eli Vazquez, Dominique Couanet, Rolf D. Kortmann, Karin Diekmann, Giovanni Scarzello, Roger Taylor, Knut Lote, Jordi Giralt, Christian Carrie, Jean Louis Habrand, Niels Soerensen, Thomas Czech, Paul Chumas, Bengt Gustavson, Michel Zerah, Bettina Wabbels, Maria Luisa Pinello, Alistair Fielder, Ian Simmons, Terje Christoffersen, Gabriele Calaminus, Knut Brockmann, Ronald Straeter, Friedrich Ebinger, Pablo Hernaiz-Driever, Herwig Lackner, Colin Kennedy, Adam Glaser, Bo Stromberg, Jose Ma Indiano, Chantal Rodary, Eric Bouffet, Didier Frappaz, Angela Emser, Suzanne Stephens, David Machin, Marie-Cécile Le Deley, Thore Egeland, Carolyn Freemann, Martin Schrappe, Richard Sposto
Publikováno v:
European Journal of Cancer
The use of chemotherapy to manage newly diagnosed low grade glioma (LGG) was first introduced in the 1980s. One randomised trial has studied two- versus four-drug regimens with a duration of 12 months of treatment after resection.Within the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ddc13a33f6fe385beac61c49f75440e
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-144933
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-144933
Autor:
Einar Stensvold, Bernt J. Due-Tønnessen, Paulina Due-Tønnessen, David Scheie, Arild Egge, Tryggve Lundar, Petter Brandal
Publikováno v:
Journal of Neurosurgery: Pediatrics. 14:598-603
Object The authors delineate the long-term results of surgical treatment for pediatric low-grade midbrain glioma. Methods A series of 15 consecutive patients (age range 0–15 years) who underwent primary tumor resection for a low-grade midbrain glio
Autor:
Astrid K. Gnekow, David A. Walker, Daniela Kandels, Susan Picton, null Giorgio Perilongo, Jacques Grill, Tore Stokland, Per Eric Sandstrom, Monika Warmuth-Metz, Torsten Pietsch, Felice Giangaspero, René Schmidt, Andreas Faldum, Denise Kilmartin, Angela De Paoli, Gian Luca De Salvo, Irene Slavc, Giorgio Perilongo, Sue Picton, David Walker, Per Erik Sandstrom, Niels Clausen, Mikko Arola, Olafur Gisli Jonsson, Ofelia Cruz, Aurora Navajas, Anna Teijeiro, Chantal Kalifa, Marie-Anne Raquin, Joris Verlooy, Volkmar Hans, Wolfram Scheurlen, Johannes Hainfellner, James Ironside, Keith Robson, Kari Skullerud, David Scheie, null NN, Marie-Madeleine Ruchoux, Anne Jouvet, Dominique Figarella-Branger, Arielle Lellouch-Toubiana, Daniela Prayer, Milena Calderone, Tim Jaspan, Soren Jacob Bakke, Eli Vazquez, Dominique Couanet, Rolf D. Kortmann, Karin Diekmann, Giovanni Scarzello, Roger Taylor, Knut Lote, Jordi Giralt, Christian Carrie, Jean Louis Habrand, Niels Soerensen, Thomas Czech, Paul Chumas, Bengt Gustavson, Michel Zerah, Bettina Wabbels, Maria Luisa Pinello, Alistair Fielder, Ian Simmons, Terje Christoffersen, Gabriele Calaminus, Knut Brockmann, Ronald Straeter, Friedrich Ebinger, Pablo Hernaiz-Driever, Herwig Lackner, Colin Kennedy, Adam Glaser, Bo Stromberg, Jose Ma Indiano, Chantal Rodary, Eric Bouffet, Didier Frappaz, Angela Emser, Suzanne Stephens, David Machin, Marie-Cécile Le Deley, Thore Egeland, Carolyn Freemann, Martin Schrappe, Richard Sposto
Publikováno v:
European Journal of Cancer
Background The use of chemotherapy to manage newly diagnosed low grade glioma (LGG) was first introduced in the 1980s. One randomised trial has studied two- versus four-drug regimens with a duration of 12 months of treatment after resection. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1b198b87ba76997a3fa8589fa2dcc7
http://hdl.handle.net/11573/1301732
http://hdl.handle.net/11573/1301732